Explore All Access
Check if your research matches the topics covered in Hematology, Transfusion and Cell Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Hematology, Transfusion and Cell Therapy : Impact Factor & More
eISSN: 2531-1387pISSN: 2531-1379
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Hematology, Transfusion and Cell Therapy Key Metrics
CiteScore 
2
Time to Publish
View Chart Mo
Topics Covered on Hematology, Transfusion and Cell Therapy
Thalassemia
Hemophagocytic lymphohistiocytosis
Cold Agglutinin
Acute chest syndrome
Pediatric population
Intensive care unit
Vaso-occlusive crisis
Cold agglutinin disease
Hematology, Transfusion and Cell Therapy Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Publication Time | 30 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE) |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months7%
4 to 6 months30%
7 to 9 months44%
Above 9 months20%
Did you find this useful?
Planning to publish in Hematology, Transfusion and Cell Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hematology, Transfusion and Cell Therapy
TRATAMENTO DA LEUCEMIA MIELÓIDE CRÔNICA COM INIBIDORES DE TIROSINO QUINASE EM SEGUNDA LINHA
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE REASONS FOR INITIATION OF FIRST-LINE TREATMENT: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
EVOLUÇÃO DOS CANDIDATOS À DOAÇÃO DE SANGUE DO GÊNERO FEMININO NO BANCO DE SANGUE DO HOSPITAL SANTA MARCELINA EM 10 ANOS
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
RECIDIVA DE LEUCEMIA MIELOIDE AGUDA (LMA) COM ACOMETIMENTO EM SISTEMA NERVOSO CENTRAL (SNC): RELATO DE CASO
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
TRATAMENTO DA LEUCEMIA MIELÓIDE CRÔNICA COM INIBIDORES DE TIROSINO QUINASE EM SEGUNDA LINHA
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE REASONS FOR INITIATION OF FIRST-LINE TREATMENT: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
EVOLUÇÃO DOS CANDIDATOS À DOAÇÃO DE SANGUE DO GÊNERO FEMININO NO BANCO DE SANGUE DO HOSPITAL SANTA MARCELINA EM 10 ANOS
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
RECIDIVA DE LEUCEMIA MIELOIDE AGUDA (LMA) COM ACOMETIMENTO EM SISTEMA NERVOSO CENTRAL (SNC): RELATO DE CASO
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS
- 1 Oct 2021
- Hematology, Transfusion and Cell Therapy
Compare Similar Journals with Hematology, Transfusion and Cell Therapy
Select Journals to Compare with Hematology, Transfusion and Cell Therapy
Total journals - 8
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
British Journal of Haematology
Publisher: WILEY
Annals of Hematology
Publisher: SPRINGER
Blood advances
Publisher: ELSEVIER
American Journal of Hematology
Publisher: WILEY
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Transfusion and Apheresis Science
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
0 Journals Selected to compare with
Hematology, Transfusion and Cell Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Hematology, Transfusion and Cell Therapy
How many articles did Hematology, Transfusion and Cell Therapy publish last year? 
In 2023, Hematology, Transfusion and Cell Therapy publsihed undefined articles.
What is the eISSN & pISSN for Hematology, Transfusion and Cell Therapy?
For Hematology, Transfusion and Cell Therapy, eISSN is 2531-1387 and pISSN is 2531-1379.
What is Citescore for Hematology, Transfusion and Cell Therapy?
Citescore for Hematology, Transfusion and Cell Therapy is 2.
Who is the publisher of Hematology, Transfusion and Cell Therapy?
Elsevier is the publisher of Hematology, Transfusion and Cell Therapy.
